Author:
Maddux Jacob T.,Inselman Jonathan W.,Jeffery Molly M.,Lam Regina W.,Shah Nilay D.,Rank Matthew A.
Funder
National Heart, Lung, and Blood Institute
Mayo Clinic
National Institutes of Health
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference15 articles.
1. Trends and disparities in asthma biologic use in the United States;Inselman;J Allergy Clin Immunol Pract,2019
2. Omalizumab treatment patterns among patients with asthma in the US Medicare population;Li;J Allergy Clin Immunol Pract,2020
3. Real-world clinical characteristics, treatment patterns, and exacerbations in US patients with asthma newly treated with omalizumab;Ke;Clin Ther,2018
4. New biologics for severe asthma: what patients, what agents, what results, at what cost?;Rabe;Am J Respir Crit Care Med,2019
5. A randomized multicenter study evaluating Xolair persistence of response after long-term therapy;Ledford;J Allergy Clin Immunol,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献